Company / FCF Margin
PLIANT THERAPEUTICS, INC. FCF Margin History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-995.3%
FY2024
5-year range
-1022.1% / -6.5%
FY2020-FY2024
Trend
+2.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -1022.1% to -995.3% over the past 2 years.
Based on SEC 10-K filings.
-995.3% in FY2024 with a 3-year CAGR of -988.8%.
Improved from -1022.1% to -995.3% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -988.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin increased 2.6% year-over-year.
- Peak fcf margin was recorded in FY2021.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -995.3% | +2.6% |
| FY2023 | -1022.1% | +0.0% |
| FY2022 | -1022.1% | -15600.9% |
| FY2021 | -6.5% | +0.0% |
| FY2020 | -6.5% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026